Allergenis
Hatfield
About Allergenis
AllerGenis is a predictive data analytics company specializing in the detection and management of life-threatening immune response disorders including food allergy. Amassing the world’s largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes to gain clinical insights, AllerGenis is leading the field in developing precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. The company was founded via a collaboration with Hugh Sampson MD, of the Icahn School of Medicine at Mount Sinai. AllerGenis owns and operates a CLIA-certified laboratory in Hatfield, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.5M
- Last round: Equity Crowdfunding (Aug 2023)
- Website: allergenis.com
- Phone: 4019652499
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/allergenis-72203 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.